pillbase.ru

INLYTA

Active substance: axitinib

TABLET, FILM COATED · AXITINIB 5 mg/1

United StatesActive

Marketing holder: Pfizer Laboratories Div Pfizer Inc

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Axitinib Accord
    axitinib
    EMEA/H/C/006206
    Accord Healthcare S.L.U.
  • Inlyta
    axitinib
    EMEA/H/C/002406
    Pfizer Europe MA EEIG
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-36ab-7a7e-8333-d72bb418079a,01a12090-4953-7a7c-8b73-66a8e0bfd472,01a12092-3255-742c-85ee-63c899b6dfad,01a1209a-2ac8-7441-9737-c1d13c93d2dc;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0069-0151
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 0069-0151 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0069-0151 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0069-0151 · Verified 2026-10-09 · open in source